About Carlos Guillem
Carlos Guillem is a director at Renibus Therapeutics.
Carlos Guillem first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Carlos Guillem in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Carlos Guillem works with at each company, as listed on that company's latest Form D.
Renibus Therapeutics, Inc. · Form D/A, Jul 17, 2025
JD
Jamie Donadio
Executive officer
BS
Bhupinder Singh
Executive officer and director
DK
D. Keyser
Chief Executive Officer and director
HR
Henrik Rasmussen
Director